Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10
Closed -$90 5464
2025
Q2
$90 Hold
10
﹤0.01% 5413
2025
Q1
$95 Hold
10
﹤0.01% 5381
2024
Q4
$194 Hold
10
﹤0.01% 5345
2024
Q3
$117 Sell
10
-202
-95% -$6.44K ﹤0.01% 5183
2024
Q2
$8.48K Sell
212
-3,067
-94% -$147K ﹤0.01% 5083
2024
Q1
$173K Sell
3,279
-226
-6% -$23.2K ﹤0.01% 4623
2023
Q4
$442K Buy
3,505
+2,788
+389% +$838K ﹤0.01% 4451
2023
Q3
$245K Sell
717
-209
-23% -$81.7K ﹤0.01% 4624
2023
Q2
$399K Buy
926
+488
+111% +$329K ﹤0.01% 4549
2023
Q1
$354K Buy
438
+88
+25% +$58.3K ﹤0.01% 4628
2022
Q4
$272K Buy
350
+259
+285% +$140K ﹤0.01% 4767
2022
Q3
$22K Sell
91
-3
-3% -$714 ﹤0.01% 5490
2022
Q2
$14K Sell
94
-1
-1% -$300 ﹤0.01% 5593
2022
Q1
$45K Sell
95
-5
-5% -$1.85K ﹤0.01% 5429
2021
Q4
$45K Buy
100
+36
+56% +$20.8K ﹤0.01% 5418
2021
Q3
$42K Sell
64
-1
-2% -$1.07K ﹤0.01% 5300
2021
Q2
$111K Buy
+65
New +$101K ﹤0.01% 5017

Other funds holding BIVI

BlackRock's BIVI Position: Q3 2025 in Review

BlackRock sold out of BioVie (BIVI) in Q3 2025, closing a stake of 10 shares — an estimated $90 sold.

BlackRock first reported a position in BIVI in Q2 2021 and held it in 17 quarters. The position peaked at $442K in Q4 2023. 32 funds tracked by Wall St. Rank hold BIVI as of Q3 2025.

  • BlackRock reported no remaining BioVie position as of Q3 2025 after selling out during the quarter.
  • BlackRock sold 10 BioVie shares in Q3 2025, an estimated $90.
  • BlackRock first reported a position in BioVie in Q2 2021 and held it in 17 quarters.
  • BlackRock's BioVie position peaked at $442K in Q4 2023.
  • 32 funds tracked by Wall St. Rank held BioVie as of Q3 2025.

Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.